Harvard Bioscience SG&A Expenses 2012-2026 | HBIO
Harvard Bioscience sg&a expenses from 2012 to 2026. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
|
Harvard Bioscience Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025 | $37 |
| 2024 | $44 |
| 2023 | $47 |
| 2022 | $50 |
| 2021 | $49 |
| 2020 | $43 |
| 2019 | $46 |
| 2018 | $46 |
| 2017 | $33 |
| 2016 | $41 |
| 2015 | $40 |
| 2014 | $35 |
| 2013 | $35 |
| 2012 | $36 |
| 2011 | $35 |
|
Harvard Bioscience Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2026-03-31 | $10 |
| 2025-12-31 | $9 |
| 2025-09-30 | $9 |
| 2025-06-30 | $9 |
| 2025-03-31 | $10 |
| 2024-12-31 | $10 |
| 2024-09-30 | $11 |
| 2024-06-30 | $11 |
| 2024-03-31 | $12 |
| 2023-12-31 | $11 |
| 2023-09-30 | $12 |
| 2023-06-30 | $12 |
| 2023-03-31 | $12 |
| 2022-12-31 | $12 |
| 2022-09-30 | $12 |
| 2022-06-30 | $13 |
| 2022-03-31 | $13 |
| 2021-12-31 | $13 |
| 2021-09-30 | $12 |
| 2021-06-30 | $12 |
| 2021-03-31 | $12 |
| 2020-12-31 | $11 |
| 2020-09-30 | $10 |
| 2020-06-30 | $10 |
| 2020-03-31 | $12 |
| 2019-12-31 | $11 |
| 2019-09-30 | $12 |
| 2019-06-30 | $11 |
| 2019-03-31 | $12 |
| 2018-12-31 | $13 |
| 2018-09-30 | $11 |
| 2018-06-30 | $12 |
| 2018-03-31 | $11 |
| 2017-12-31 | $9 |
| 2017-09-30 | $8 |
| 2017-06-30 | $8 |
| 2017-03-31 | $8 |
| 2016-12-31 | $10 |
| 2016-09-30 | $10 |
| 2016-06-30 | $10 |
| 2016-03-31 | $11 |
| 2015-12-31 | $10 |
| 2015-09-30 | $10 |
| 2015-06-30 | $10 |
| 2015-03-31 | $10 |
| 2014-12-31 | $10 |
| 2014-09-30 | $8 |
| 2014-06-30 | $9 |
| 2014-03-31 | $9 |
| 2013-12-31 | $9 |
| 2013-09-30 | $9 |
| 2013-06-30 | $9 |
| 2013-03-31 | $9 |
| 2012-12-31 | $8 |
| 2012-09-30 | $10 |
| 2012-06-30 | $10 |
| 2012-03-31 | $10 |
| 2011-12-31 | $9 |
| 2011-09-30 | $9 |
| 2011-06-30 | $8 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $0.019B | $0.087B |
| HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bruker (BRKR) | United States | $5.722B | 20.54 |
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |